Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.
about
Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a ReinfectionBoth Cyclophilin Inhibitors and Direct-Acting Antivirals Prevent PKR Activation in HCV-Infected Cells.Cyclophilin and NS5A inhibitors, but not other anti-hepatitis C virus (HCV) agents, preclude HCV-mediated formation of double-membrane-vesicle viral factoriesThermo-kinetic analysis space expansion for cyclophilin-ligand interactions - identification of a new nonpeptide inhibitor using Biacore™ T200.Interplay between Hepatitis C Virus and Redox Cell Signaling.The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.Imino sugar glucosidase inhibitors as broadly active anti-filovirus agentsHCV core protein and virus assembly: what we know without structures.Multiple mutations in hepatitis C virus NS5A domain II are required to confer a significant level of resistance to alisporivirInhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexes.HCV NS5A and IRF9 compete for CypA binding.Modeling viral kinetics and treatment outcome during alisporivir interferon-free treatment in hepatitis C virus genotype 2 and 3 patients.
P2860
Q27468931-2C681B4E-C67D-42B0-93F0-13996CCBECF5Q33565080-8A2B095E-9BE8-498B-B477-38F729120442Q35385005-93F94414-412A-47C5-B336-017A6AA9D660Q36342708-37C52146-6FC9-4621-BD00-977021E08131Q36790471-A750973E-B035-44BE-AA94-2FBE61700191Q37400658-9F727574-8AB1-40C0-B265-F3247636BC60Q37584342-CBA3C93C-0998-4F1C-A877-D05ABDAF3AC9Q38190014-4DDB89B0-48B6-4A2E-A153-2604A3D4658BQ39313413-C8D99A74-0C7C-4426-9B1C-E7C206A2F1CDQ40093537-C98A8CE4-4668-4C1F-8F53-F482269A7EB6Q41843629-53D09CA4-DEB8-4F40-8B3F-17282C526291Q42068187-10580F05-0AA7-4853-AFED-A92FD8EEE600Q42246268-FD5750A8-7040-45EA-A070-7D75899660C9
P2860
Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.
@en
Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.
@nl
type
label
Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.
@en
Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.
@nl
prefLabel
Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.
@en
Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.
@nl
P2860
P1433
P1476
Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.
@en
P2093
Philippe A Gallay
P2860
P2888
P304
P356
10.1007/S12026-011-8263-5
P577
2012-06-01T00:00:00Z